|
US20020137890A1
(en)
*
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20060160181A1
(en)
*
|
2000-02-15 |
2006-07-20 |
Amgen Inc. |
Fibroblast Growth Factor-23 molecules and uses thereof
|
|
WO2001066595A2
(en)
*
|
2000-03-08 |
2001-09-13 |
Chiron Corporation |
Human fgf-23 gene and gene expression products
|
|
EP2233571B1
(en)
*
|
2000-08-11 |
2012-11-07 |
Kyowa Hakko Kirin Co., Ltd. |
Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAS encoding the same
|
|
US6838264B2
(en)
|
2000-12-05 |
2005-01-04 |
Immutopics, Inc. |
Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
|
|
US7226749B2
(en)
|
2000-12-05 |
2007-06-05 |
Zahradnik Richard J |
Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
|
|
IL156504A0
(en)
*
|
2000-12-26 |
2004-01-04 |
Chugai Pharmaceutical Co Ltd |
Human fgf23 protein mutant lowering blood phosphorus level
|
|
US20040171825A1
(en)
*
|
2001-04-26 |
2004-09-02 |
Lydie Bougueleret |
Human fibroblast growth factor-related compositions
|
|
JP4527982B2
(ja)
*
|
2001-12-28 |
2010-08-18 |
協和発酵キリン株式会社 |
線維芽細胞増殖因子−２３に対する抗体
|
|
US7094551B2
(en)
|
2002-09-17 |
2006-08-22 |
Zahradnik Richard J |
Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
|
|
DE602004032457D1
(de)
*
|
2003-11-07 |
2011-06-09 |
Novartis Ag |
Nten
|
|
EP1745151B1
(en)
*
|
2004-05-09 |
2009-12-02 |
Technion Research And Development Foundation, Ltd. |
Methods relating to disorders associated with abnormal phosphate metabolism
|
|
IL161886A0
(en)
*
|
2004-05-09 |
2005-11-20 |
Technion Res & Dev Foundation |
Development of inducers of udp-n-acetyl-alphad-galactosamine: polypeptide n-acetylgalactosami-nyltransferase 3(ppgantase
|
|
BRPI0612974A2
(pt)
*
|
2005-04-18 |
2010-12-14 |
Clearplay Inc |
produto de programa de computador, sinal de dados de computador incorporado em uma mÍdia de transmissço, mÉtodo para associar uma apresentaÇço de multimÍdia com informaÇÕes de filtro de conteédo e reprodutor de multimÍdia
|
|
KR100760525B1
(ko)
*
|
2006-04-13 |
2007-10-04 |
김재만 |
병원성 미생물의 무증폭 다중 정량 검출킷트 및 검출방법
|
|
US8012694B2
(en)
|
2006-09-14 |
2011-09-06 |
Immutopics, Inc. |
Assay for the detection of phosphorylated PTH
|
|
US8058015B2
(en)
|
2007-01-22 |
2011-11-15 |
Medizinische Universität Innsbruck |
Markers for chronic kidney disease
|
|
US7883705B2
(en)
|
2007-02-14 |
2011-02-08 |
Kyowa Hakko Kirin Co., Ltd. |
Anti FGF23 antibody and a pharmaceutical composition comprising the same
|
|
WO2009091556A2
(en)
*
|
2008-01-17 |
2009-07-23 |
The General Hospital Corporation |
Diagnostic methods and kits using fibroblast growth factor-23
|
|
TW200936156A
(en)
|
2008-01-28 |
2009-09-01 |
Novartis Ag |
Methods and compositions using Klotho-FGF fusion polypeptides
|
|
US8420088B2
(en)
*
|
2008-01-28 |
2013-04-16 |
Novartis Ag |
Methods and compositions using FGF23 fusion polypeptides
|
|
TWI526687B
(zh)
*
|
2008-04-29 |
2016-03-21 |
諾華公司 |
生物標記
|
|
US8889621B2
(en)
*
|
2009-10-30 |
2014-11-18 |
New York University |
Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of hypophosphatemia
|
|
US20110195077A1
(en)
|
2010-01-29 |
2011-08-11 |
Novartis Ag |
Methods and compositions using fgf23 fusion ppolypeptides
|
|
US10422796B2
(en)
|
2010-08-31 |
2019-09-24 |
Kyowa Medex Co., Ltd. |
Method for measuring fibroblast growth factor-23 and reagent therefor
|
|
WO2012055096A1
(zh)
*
|
2010-10-27 |
2012-05-03 |
温州医学院生物与天然药物开发中心有限公司 |
抗fgf-23抗体的制备方法及用途
|
|
US20140294820A1
(en)
|
2011-06-24 |
2014-10-02 |
University Of Miami |
Fibroblast growth factor receptor inhibition for the treatment of disease
|
|
CN105601748B
(zh)
|
2011-07-01 |
2021-08-27 |
恩格姆生物制药公司 |
用于代谢病症和疾病治疗的组合物、应用和方法
|
|
WO2013027191A1
(en)
|
2011-08-25 |
2013-02-28 |
Novartis Ag |
Methods and compositions using fgf23 fusion polypeptides
|
|
US9657075B2
(en)
|
2012-06-07 |
2017-05-23 |
New York University |
Chimeric fibroblast growth factor 23 proteins and methods of use
|
|
HK1214832A1
(zh)
|
2012-11-28 |
2016-08-05 |
恩格姆生物制药公司 |
用於代謝病症和疾病治療的組合物和方法
|
|
US9290557B2
(en)
|
2012-11-28 |
2016-03-22 |
Ngm Biopharmaceuticals, Inc. |
Compositions comprising variants and fusions of FGF19 polypeptides
|
|
US9273107B2
(en)
|
2012-12-27 |
2016-03-01 |
Ngm Biopharmaceuticals, Inc. |
Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
|
|
ES2915851T3
(es)
|
2012-12-27 |
2022-06-27 |
Ngm Biopharmaceuticals Inc |
Péptidos quiméricos de FGF19 para usar en el tratamiento de trastornos de ácidos biliares
|
|
US9550820B2
(en)
|
2013-02-22 |
2017-01-24 |
New York University |
Chimeric fibroblast growth factor 23/fibroblast growth factor 19 proteins and methods of use
|
|
CN106164255B
(zh)
*
|
2013-09-20 |
2020-02-14 |
隆萨有限公司 |
细胞的核重编程的方法
|
|
CA2927592C
(en)
|
2013-10-28 |
2020-08-18 |
Ngm Biopharmaceuticals, Inc. |
Fgf-19 variants for treating a fgf-19 dependent cancer or tumor
|
|
PE20170256A1
(es)
|
2014-01-24 |
2017-04-22 |
Ngm Biopharmaceuticals Inc |
Proteinas de union y sus metodos de uso
|
|
US10464979B2
(en)
|
2014-03-28 |
2019-11-05 |
New York University |
FGF23 c-tail fusion proteins
|
|
WO2015183890A2
(en)
|
2014-05-28 |
2015-12-03 |
Ngm Biopharmaceuticals, Inc. |
Methods and compositions for the treatment of metabolic disorders and diseases
|
|
MX381052B
(es)
|
2014-06-09 |
2025-03-12 |
Ultragenyx Pharmaceutical Inc |
El control efectivo y eficaz del fosfato serico para una osificacion optima.
|
|
AU2015277438B2
(en)
|
2014-06-16 |
2020-02-27 |
Ngm Biopharmaceuticals, Inc. |
Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
|
|
RU2729161C2
(ru)
|
2014-10-23 |
2020-08-04 |
ЭнДжиЭм БАЙОФАРМАСЬЮТИКАЛЗ, ИНК. |
Фармацевтические композиции, содержащие варианты пептидов, и способы их применения
|
|
US10434144B2
(en)
|
2014-11-07 |
2019-10-08 |
Ngm Biopharmaceuticals, Inc. |
Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders
|
|
AU2015356643B2
(en)
|
2014-12-04 |
2019-01-24 |
Novartis Ag |
Methods and compositions using Klotho variant polypeptides
|
|
CN105699664A
(zh)
*
|
2015-04-13 |
2016-06-22 |
陈柏龄 |
Fgf23检测试剂盒及其制备方法
|
|
US10808015B2
(en)
|
2015-06-25 |
2020-10-20 |
Amyris, Inc. |
Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds
|
|
US10800843B2
(en)
|
2015-07-29 |
2020-10-13 |
Ngm Biopharmaceuticals, Inc. |
Beta klotho-binding proteins
|
|
JP6728352B2
(ja)
|
2015-11-09 |
2020-07-22 |
エヌジーエム バイオファーマシューティカルス，インコーポレーテッド |
胆汁酸に関係した障害の治療方法
|
|
CA3034399A1
(en)
|
2016-08-26 |
2018-03-01 |
Ngm Biopharmaceuticals, Inc. |
Methods of treating fibroblast growth factor 19-mediated cancers and tumors
|
|
CN110494559B
(zh)
*
|
2017-03-28 |
2023-10-31 |
味之素株式会社 |
不分化地维持用培养基添加剂
|
|
WO2018221544A1
(ja)
|
2017-05-31 |
2018-12-06 |
協和メデックス株式会社 |
線維芽細胞増殖因子－２３の測定方法、測定試薬及び測定キット
|
|
WO2020047475A1
(en)
*
|
2018-08-30 |
2020-03-05 |
The Uab Research Foundation |
Drug screening for fgf23-fgfr4 inhibitors
|
|
BR112021019337A2
(pt)
*
|
2019-03-29 |
2021-12-07 |
Atarga Llc |
Anticorpo anti-fgf23
|
|
JP7654562B2
(ja)
*
|
2019-04-19 |
2025-04-01 |
ジェネトン |
線維芽細胞増殖因子２３関連低リン血症性疾患の遺伝子療法
|